Back to search

Article

SETD7 is a novel therapeutic target for multiple myeloma with t(11;14)+

2025-09-03

Abstract excerpt

<title>Abstract</title> <p>The prognosis of patients with multiple myeloma (MM) harboring t(11;14) is controversial. However, the latest retrospective analysis revealed that t(11;14) is a poor prognostic factor. MM with t(11;14) is resistant to key drugs other than immunomodulatory drugs (IMiDs); therefore, treatment for MM with t(11;14) refractory to IMiDs are an unmet medical need. This study searched for novel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c962814-d49e-5e38-99e8-fe35b53d6453
DOI
10.21203/rs.3.rs-7431598/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SETD7 is a novel therapeutic target for multiple myeloma with t(11;14)+DOI 10.21203/rs.3.rs-7431598/v1
Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma.Semantic proximity
c‐FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myelomaSemantic proximity
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myelomaSemantic proximity
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaSemantic proximity
The Role of Histone Methyltransferase SETDB1 in Normal and Malignant HematopoiesisSemantic proximity
REIIBP promotes TLR7-BTK-IL6 pro-inflammatory response through histone H3 lysine methylation in t(4;14) myelomagenesisSemantic proximity
DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signalingSemantic proximity
Expression Status and Prognostic Roles of m6A-related Genes in Multiple Myeloma: YTHDF2 as the independent prognostic factorSemantic proximity
SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple MyelomaSemantic proximity
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple MyelomaSemantic proximity
The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMMSemantic proximity
Overexpression of SETD7 is Associated with Progression of Ovarian CancerSemantic proximity
Select a neighboring publication to make it the new centre.